Your browser doesn't support javascript.
loading
Pathogenic mitochondrial mt-tRNA(Ala) variants are uniquely associated with isolated myopathy.
Lehmann, Diana; Schubert, Kathrin; Joshi, Pushpa R; Hardy, Steven A; Tuppen, Helen A L; Baty, Karen; Blakely, Emma L; Bamberg, Christian; Zierz, Stephan; Deschauer, Marcus; Taylor, Robert W.
Afiliação
  • Lehmann D; Department of Neurology, University of Halle-Wittenberg, Halle (Saale), Germany.
  • Schubert K; Department of Neurology, University of Halle-Wittenberg, Halle (Saale), Germany.
  • Joshi PR; Department of Neurology, University of Halle-Wittenberg, Halle (Saale), Germany.
  • Hardy SA; Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, UK.
  • Tuppen HA; Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, UK.
  • Baty K; Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, UK.
  • Blakely EL; Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, UK.
  • Bamberg C; Department of Neurology, Rhein-Mosel-Fachklinik, Andernach, Germany.
  • Zierz S; Department of Neurology, University of Halle-Wittenberg, Halle (Saale), Germany.
  • Deschauer M; Department of Neurology, University of Halle-Wittenberg, Halle (Saale), Germany.
  • Taylor RW; Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, UK.
Eur J Hum Genet ; 23(12): 1735-8, 2015 Dec.
Article em En | MEDLINE | ID: mdl-25873012
Pathogenic mitochondrial DNA (mtDNA) point mutations are associated with a wide range of clinical phenotypes, often involving multiple organ systems. We report two patients with isolated myopathy owing to novel mt-tRNA(Ala) variants. Muscle biopsy revealed extensive histopathological findings including cytochrome c oxidase (COX)-deficient fibres. Pyrosequencing confirmed mtDNA heteroplasmy for both mutations (m.5631G>A and m.5610G>A) whilst single-muscle fibre segregation studies (revealing statistically significant higher mutation loads in COX-deficient fibres than in COX-positive fibres), hierarchical mutation segregation within patient tissues and decreased steady-state mt-tRNA(Ala) levels all provide compelling evidence of pathogenicity. Interestingly, both patients showed very high-mutation levels in all tissues, inferring that the threshold for impairment of oxidative phosphorylation, as evidenced by COX deficiency, appears to be extremely high for these mt-tRNA(Ala) variants. Previously described mt-tRNA(Ala) mutations are also associated with a pure myopathic phenotype and demonstrate very high mtDNA heteroplasmy thresholds, inferring at least some genotype:phenotype correlation for mutations within this particular mt-tRNA gene.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Mitocondrial / RNA de Transferência de Alanina / Doenças Musculares / Mutação Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Mitocondrial / RNA de Transferência de Alanina / Doenças Musculares / Mutação Idioma: En Ano de publicação: 2015 Tipo de documento: Article